{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:21:32Z","timestamp":1793496092238,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00401-019-01961-w","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T05:56:36Z","timestamp":1549346196000},"page":"455-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation"],"prefix":"10.1007","volume":"137","author":[{"given":"Hiroaki","family":"Sekiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomo","family":"Kowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Satake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonobu","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Funakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Jinnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Kanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"1961_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2017) Alpha-synuclein oligomers: a new hope. Acta Neuropathol 134:819\u2013838. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1755-1","journal-title":"Acta Neuropathol"},{"key":"1961_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. \n                    https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"1961_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/nan.12362","volume":"43","author":"J Brettschneider","year":"2017","unstructured":"Brettschneider J, Irwin DJ, Boluda S, Byrne MD, Fang L, Lee EB et al (2017) Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol Appl Neurobiol 43:315\u2013329. \n                    https:\/\/doi.org\/10.1111\/nan.12362","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1961_CR4","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awq158","volume":"133","author":"RG Brown","year":"2010","unstructured":"Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382\u20132393. \n                    https:\/\/doi.org\/10.1093\/brain\/awq158","journal-title":"Brain"},{"key":"1961_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J (2015) The synaptic function of \u03b1-synuclein. J Parkinsons Dis 5:699\u2013713. \n                    https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Parkinsons Dis"},{"key":"1961_CR6","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK (2012) Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in -synucleinopathy in vivo. J Neurosci 32:3301\u20133305. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5368-11.2012","journal-title":"J Neurosci"},{"key":"1961_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/brain\/awv114","volume":"138","author":"MD Cykowski","year":"2015","unstructured":"Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA et al (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138:2293\u20132309. \n                    https:\/\/doi.org\/10.1093\/brain\/awv114","journal-title":"Brain"},{"key":"1961_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/2051-5960-1-54","volume":"1","author":"A Dan","year":"2013","unstructured":"Dan A, Takahashi M, Masuda-Suzukake M, Kametani F, Nonaka T, Kondo H et al (2013) Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer\u2019s disease brain. Acta Neuropathol Commun 1:54. \n                    https:\/\/doi.org\/10.1186\/2051-5960-1-54","journal-title":"Acta Neuropathol Commun"},{"key":"1961_CR9","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A et al (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220\u20139232. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2617-07.2007","journal-title":"J Neurosci"},{"key":"1961_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","volume":"155","author":"DW Dickson","year":"1999","unstructured":"Dickson DW, Liu W, Hardy J, Farrer M, Mehta N, Uitti R et al (1999) Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 155:1241\u20131251. \n                    https:\/\/doi.org\/10.1097\/00005072-199905000-00191","journal-title":"Am J Pathol"},{"key":"1961_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OMA El-Agnaf","year":"2006","unstructured":"El-Agnaf OMA (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20:419\u2013425. \n                    https:\/\/doi.org\/10.1096\/fj.03-1449com","journal-title":"FASEB J"},{"key":"1961_CR12","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838\u20136851. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5699-09.2010","journal-title":"J Neurosci"},{"key":"1961_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-System Atrophy. N Engl J Med 372:249\u2013263. \n                    https:\/\/doi.org\/10.1056\/NEJMra1311488","journal-title":"N Engl J Med"},{"key":"1961_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.26624","volume":"31","author":"G Forloni","year":"2016","unstructured":"Forloni G, Artuso V, La Vitola P, Balducci C (2016) Oligomeropathies and pathogenesis of Alzheimer and Parkinson\u2019s diseases. Mov Disord 31:771\u2013781. \n                    https:\/\/doi.org\/10.1002\/mds.26624","journal-title":"Mov Disord"},{"key":"1961_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) \u0391-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. \n                    https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"1961_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"key":"1961_CR17","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/mds.20537","volume":"20","author":"KA Jellinger","year":"2005","unstructured":"Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20:S29\u2013S36. \n                    https:\/\/doi.org\/10.1002\/mds.20537","journal-title":"Mov Disord"},{"key":"1961_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2202-11-124","volume":"11","author":"M Kamali-moghaddam","year":"2010","unstructured":"Kamali-moghaddam M, Pettersson FE, Wu D, Englund H, Darmanis S, Lord A et al (2010) Sensitive detection of A b protofibrils by proximity ligation\u2014relevance for Alzheimer\u2019s disease. BMC Neurosci 11:124","journal-title":"BMC Neurosci"},{"key":"1961_CR19","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MBG, K\u00fcgler S, Opazo F, Rezaei-Ghaleh N, Wender N et al (2009) Pre-fibrillar \u03b1-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J 28:3256\u20133268. \n                    https:\/\/doi.org\/10.1038\/emboj.2009.257","journal-title":"EMBO J"},{"key":"1961_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1468-1331.2009.02544.x","volume":"16","author":"M Kitayama","year":"2009","unstructured":"Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2009) Assessment of dementia in patients with multiple system atrophy. Eur J Neurol 16:589\u2013594. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02544.x","journal-title":"Eur J Neurol"},{"key":"1961_CR21","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE et al (1998) Diffusible, nonfibrillar ligands derived from Abeta 1\u201342 are potent central nervous system neurotoxins. Proc Natl Acad Sci 95:6448\u20136453. \n                    https:\/\/doi.org\/10.1073\/pnas.95.11.6448","journal-title":"Proc Natl Acad Sci"},{"key":"1961_CR22","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1021\/bi1016233","volume":"49","author":"CA Lasagna-Reeves","year":"2010","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Jackson GR, Kayed R (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49:10039\u201310041. \n                    https:\/\/doi.org\/10.1021\/bi1016233","journal-title":"Biochemistry"},{"key":"1961_CR23","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, H\u00f8jrup P, Moos T, Gai W, Hendil KB, Jensen PH (2004) Proteasomal inhibition by \u03b1-synuclein filaments and oligomers. J Biol Chem 279:12924\u201312934. \n                    https:\/\/doi.org\/10.1074\/jbc.M306390200","journal-title":"J Biol Chem"},{"key":"1961_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/mds.26220","volume":"30","author":"H Ling","year":"2015","unstructured":"Ling H, Asi YT, Petrovic IN, Ahmed Z, Prashanth LK, Hazrati LN et al (2015) Minimal change multiple system atrophy: an aggressive variant? Mov Disord 30:960\u2013967. \n                    https:\/\/doi.org\/10.1002\/mds.26220","journal-title":"Mov Disord"},{"key":"1961_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK et al (2010) Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65:66\u201379. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2009.12.023","journal-title":"Neuron"},{"key":"1961_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C et al (2001) The \u201cArctic\u201d APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced A\u03b2 protofibril formation. Nat Neurosci 4:887\u2013893. \n                    https:\/\/doi.org\/10.1038\/nn0901-887","journal-title":"Nat Neurosci"},{"key":"1961_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/annotation\/9282f173-df82-4b70-9120-b4e62b3dacb1","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F et al (2008) Formation of toxic oligomeric \u03b1-synuclein species in living cells. PLoS One 3:1\u20139. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0001867","journal-title":"PLoS One"},{"key":"1961_CR28","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657\u20132671. \n                    https:\/\/doi.org\/10.1093\/brain\/awh303","journal-title":"Brain"},{"key":"1961_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79\u2013100. \n                    https:\/\/doi.org\/10.1016\/0022-510X(89)90219-0","journal-title":"J Neurol Sci"},{"key":"1961_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40699","volume":"7","author":"N Plotegher","year":"2017","unstructured":"Plotegher N, Berti G, Ferrari E, Tessari I, Zanetti M, Lunelli L et al (2017) DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. Sci Rep 7:1\u201316. \n                    https:\/\/doi.org\/10.1038\/srep40699","journal-title":"Sci Rep"},{"key":"1961_CR31","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.bbagen.2014.02.013","volume":"1840","author":"N Plotegher","year":"2014","unstructured":"Plotegher N, Gratton E, Bubacco L (2014) Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells. Biochim Biophys Acta Gen Subj 1840:2014\u20132024. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2014.02.013","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1961_CR32","doi-asserted-by":"publisher","first-page":"201713129","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots I, Grosch J, Brazdis R-M, Simmnacher K, Veber V, Havlicek S et al (2018) \u03b1-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci 115:201713129. \n                    https:\/\/doi.org\/10.1073\/pnas.1713129115","journal-title":"Proc Natl Acad Sci"},{"key":"1961_CR33","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/brain\/awv040","volume":"138","author":"RF Roberts","year":"2015","unstructured":"Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2015) Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain. Brain 138:1642\u20131657. \n                    https:\/\/doi.org\/10.1093\/brain\/awv040","journal-title":"Brain"},{"key":"1961_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","volume":"3","author":"O S\u00f6derberg","year":"2006","unstructured":"S\u00f6derberg O, Gullberg M, Jarvius M, Ridderstr\u00e5le K, Leuchowius KJ, Jarvius J et al (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3:995\u20131000. \n                    https:\/\/doi.org\/10.1038\/nmeth947","journal-title":"Nat Methods"},{"key":"1961_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.25880","volume":"29","author":"I Stankovic","year":"2014","unstructured":"Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG et al (2014) Cognitive impairment in multiple system atrophy: a position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group. Mov Disord 29:857\u2013867. \n                    https:\/\/doi.org\/10.1002\/mds.25880","journal-title":"Mov Disord"},{"key":"1961_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"T Tomiyama","year":"2008","unstructured":"Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H et al (2008) A new amyloid \u03b2 variant favoring oligomerization in Alzheimer\u2019s-type dementia. Ann Neurol 63:377\u2013387. \n                    https:\/\/doi.org\/10.1002\/ana.21321","journal-title":"Ann Neurol"},{"key":"1961_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","volume":"3","author":"A Uchino","year":"2015","unstructured":"Uchino A, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A et al (2015) Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol Commun 3:35. \n                    https:\/\/doi.org\/10.1186\/s40478-015-0215-1","journal-title":"Acta Neuropathol Commun"},{"key":"1961_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) \u0391-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180\u2013182. \n                    https:\/\/doi.org\/10.1016\/S0304-3940(98)00407-8","journal-title":"Neurosci Lett"},{"key":"1961_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21465","volume":"64","author":"GK Wenning","year":"2008","unstructured":"Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG (2008) Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 64:239\u2013246. \n                    https:\/\/doi.org\/10.1002\/ana.21465","journal-title":"Ann Neurol"},{"key":"1961_CR40","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S et al (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci 108:4194\u20134199. \n                    https:\/\/doi.org\/10.1073\/pnas.1100976108","journal-title":"Proc Natl Acad Sci"},{"key":"1961_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1440-1789.2007.00841.x","volume":"27","author":"M Yoshida","year":"2007","unstructured":"Yoshida M (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 27:484\u2013493. \n                    https:\/\/doi.org\/10.1111\/j.1440-1789.2007.00841.x","journal-title":"Neuropathology"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-01961-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01961-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01961-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:09:40Z","timestamp":1580843380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-01961-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1961"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-01961-w","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the families of all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}